USPTO serial 88089565
COMPOUNDING HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 31, 2022
- Examiner
- WRIGHT, MARCO JABBAR
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COMPOUNDING HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ENGLEWOOD, CO
ENGLEWOOD, CO
San Jose, CA
San Jose, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet M. Garetto
Janet M. Garetto NIXON PEABODY LLP70 W. MADISON STREET, SUITE 5200CHICAGO, IL 60602-4378UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Intravenous bags sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Vials sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time which are sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LEITERS, INC.
- Other trademarks owned by LEITERS, INC.
- Other trademarks owned by Leiter's Enterprises, Inc.
- Other trademarks owned by Leiter's Enterprises, Inc.
- Other trademarks in Class 005
- Similar marks named COMPOUNDING HEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 31, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 23, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 22, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 18, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 11, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 23, 2022 | IUAF | USE AMENDMENT FILED | — |
| Mar 23, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 27, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 27, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 25, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 23, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 23, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 23, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 11, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 9, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 9, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 9, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 25, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 23, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 23, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 23, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 25, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 23, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 23, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 23, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 24, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 21, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 17, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 12, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 12, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 12, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 12, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 15, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2018 | NWAP | NEW APPLICATION ENTERED | — |